ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 88 filers reported holding ONCOCYTE CORP in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,359,245 | -27.7% | 719,282 | -94.9% | 0.35% | -21.4% |
| Q2 2023 | $3,262,703 | +35.9% | 14,185,664 | +109.4% | 0.44% | +36.3% |
| Q1 2023 | $2,400,369 | +3.1% | 6,773,051 | -6.6% | 0.32% | -3.3% |
| Q4 2022 | $2,327,880 | -58.8% | 7,254,222 | -6.4% | 0.34% | -60.9% |
| Q3 2022 | $5,655,000 | -18.9% | 7,746,557 | 0.0% | 0.86% | -21.7% |
| Q2 2022 | $6,970,000 | +1836.1% | 7,746,557 | +3102.8% | 1.10% | +2287.0% |
| Q1 2022 | $360,000 | -31.4% | 241,867 | 0.0% | 0.05% | -13.2% |
| Q4 2021 | $525,000 | -79.4% | 241,867 | -66.3% | 0.05% | -78.9% |
| Q3 2021 | $2,553,000 | -33.3% | 717,000 | +7.5% | 0.25% | -33.6% |
| Q2 2021 | $3,829,000 | -1.6% | 667,000 | -11.1% | 0.38% | -13.1% |
| Q1 2021 | $3,892,000 | – | 750,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |